ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1546020

This article is part of the Research TopicInnovation in Tackling the Global Challenge of Eradicating Antibiotic-Resistant MicroorganismsView all 11 articles

Screening and transcriptomic analysis of anti-Sporothrix globosa targeting AbaA

Provisionally accepted
Ying  WangYing Wang1Xiaoyan  WuXiaoyan Wu2Xiyuan  FanXiyuan Fan1Chanxu  HanChanxu Han2Fangliang  ZhengFangliang Zheng1*Zhenying  ZhangZhenying Zhang2,3*
  • 1Liaoning University, Shenyang, China
  • 2Department of Dermatology, Shenzhen Hospital, The University of Hong Kong, Shenzhen, Guangdong Province, China
  • 3Department of Dermatology, The eighth affiliated hospital, SUN YAT-SEN University, Shenzhen, China

The final, formatted version of the article will be published soon.

Sporotrichosis is a fungal disease caused by a complex of Sporothrix schenckii, leading to chronic infections of the epidermis and subcutaneous tissue in both humans and animals. The emergence of drug-resistant strains in sporotrichosis has highlighted the urgent need to identify new drug targets. In this study, we measured growth curves, minimum bactericidal concentration (MBC), and minimum inhibitory concentration (MIC) for both Sporothrix globosa (S. globosa) and Sporothrix schenckii (S. schenckii). The results confirmed that both Azelastine and Mefloquine significantly inhibited the growth of these fungi. Additionally, animal experiments demonstrated that these drugs reduced skin lesions in mice, and post-treatment observations revealed improvements in inflammatory infiltration and granuloma formation. In conclusion, Azelastine and Mefloquine exhibit the potential to inhibit Sporothrix and treat sporotrichosis both in vitro and in murine models, they may inhibit fungal growth by binding to a crucial fungal target, the AbaA protein, or by modulating the host's immune response, suggesting their potential as therapeutic agents for this condition. Furthermore, we utilized bioinformatics to predict virulence factors regulated by the abaA gene. Through transcriptome analysis and qRT-PCR for validation, our findings demonstrate that the abaA gene plays a crucial role in regulating the attachment of the Sporothrix cell wall to the host matrix and in melanin regulation. Notably, when the abaA gene was inhibited, there was a marked increase in the expression of repair genes. These results emphasize the significance of the abaA gene in the biology of Sporothrix.

Keywords: Sporothrix globosa 1, abaA gene 2, Virtual screening 3, Small molecule drugs 4, Transcriptomics 5

Received: 16 Dec 2024; Accepted: 11 Apr 2025.

Copyright: © 2025 Wang, Wu, Fan, Han, Zheng and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Fangliang Zheng, Liaoning University, Shenyang, China
Zhenying Zhang, Department of Dermatology, Shenzhen Hospital, The University of Hong Kong, Shenzhen, 518052, Guangdong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.